Providers and patients fish for that delicate balance between access and abandonment.
Alison King
Advertisement
Articles by Alison King
Advertisement
Latest Updated Articles
Who Pays for Specialty Medicines?Published: November 1st 2012 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
2
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
3
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
4
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
5
